Company news

LTR Pharma Limited news in 2024

LTR Pharma Limited's news releases, calls and decks from 2024, newest first.

View company

Response to ASX Query Letters

December 30, 2024

Agreement with Men's Health Pharmacy for SPONTAN access

December 18, 2024

Early Launch of Online Mens Health Platform

December 11, 2024

LTR Pharma Announces Successful A$25 million Placement

December 9, 2024

Trading Halt

December 5, 2024

JV with Leading Men's Health Group for Online Platform

November 11, 2024

SPONTAN Final Study Results

October 13, 2024

FY24 Results Announcement

August 29, 2024

Appendix 4E and Annual Financial Report

August 29, 2024

SPONTAN Prescribed to First Patient by Authorised Prescriber

August 15, 2024

LTP Secures Global CoDevelopment Agreement with Aptar Pharma

August 12, 2024

Mens Health Expert Prescribes SPONTAN

August 7, 2024

SPONTAN prescribed to First Patient Under TGA

August 4, 2024

LTR Pharma completes A$10.5 million placement

July 23, 2024

SPONTAN achieves positive clinical study results

June 7, 2024

Reinstatement to quotation

June 7, 2024

Suspension from Quotation

June 6, 2024

Response to ASX Price Query

May 22, 2024

Final Patients dosed in SPONTAN pivotal study

March 24, 2024

First patients dosed in SPONTAN pivotal study

March 18, 2024

Recruitment commences for SPONTAN Clinical Study

February 18, 2024

SPONTAN Achieves Key Manufacturing Validation

February 5, 2024

Decks in 2024